Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Expert InterviewsAround the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsTraining AcademyTreatment Algorithms with the Oncology Brothers
Conferences
All JournalsEditorial BoardFor AuthorsYear in Review
Frontline ForumSatellite Sessions
CME/CE
Awareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career CenterSubscribe
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
Spotlight -
  • Radiation Oncology
  • Surgery
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
    • Conferences
    • CME/CE
    • Career Center
    • Subscribe
Advertisement

Morning Rounds


A panel of 3 experts on multiple myeloma

Relapsed/Refractory Multiple Myeloma Treatment Decision Making

March 12th 2024

A panel of experts on multiple myeloma review a clinical scenario and offer comprehensive insights on treatment practices for patients with relapsed/refractory disease.


Relapsed/Refractory Multiple Myeloma Treatment Decision Making

Relapsed/Refractory Multiple Myeloma Treatment Decision Making

December 12th 2023

Three experts on multiple myeloma review a patient case and discuss best practices and treatment strategies for patients with relapsed/refractory multiple myeloma.


Experts on RCC

Treatment Strategies for Advanced Renal Cell Carcinoma

November 6th 2023

Expert panelists from the Dana-Farber Cancer Institute review the current treatment landscape of metastatic clear cell kidney cancer and consider how they integrate new management strategies within their own clinic.


Experts on bladder cancer

The Bladder Cancer Treatment Paradigm

June 26th 2023

Expert panelists review the current treatment landscape of bladder cancer and consider how recent clinical data have impacted their practice.


Experts on RCC

Metastatic Renal Cell Carcinoma Decision-Making

March 30th 2023

Key opinion leaders in the field of renal cell carcinoma management center discussion on clinical scenarios to discuss the workup and treatment of patients with metastatic disease.


Experts on lung cancer

Non-Small Cell Lung Cancer EGFR Testing and Treatment

August 26th 2022

Expert oncologists review clinical scenarios to define best treatment practices for patients with EGFR-mutated non–small cell lung cancer.

Advertisement
About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Editorial
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.